The US FDA approved the first generic referencing Victoza, a GLP-1 receptor agonist indicated to improve glycemic control.
Fast subjective walking speed is associated with lower odds of metabolic diseases among individuals with obesity.
Federal health officials have confirmed unsettling details about the first United States case of severe bird flu.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback